Manufacturer record
Sterlife Pharma Pvt Ltd: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Sterlife Pharma Pvt Ltd (Gujarat) were declared Not of Standard Quality between April 2019 and June 2024. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
2 records linked to Sterlife Pharma Pvt Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Lytraco 200 Itraconazole Capsules 200 mg | SLP-22445Mfg 2023-02 · Exp 2025-01 | THE SAMPLE DOES NOT COMPLY WITH B P REQUIREMENTS FOR DISSOLUTION TEST THE SAMPLE IS OFFICIAL IN B P 2021 THEREFORE THE SAMPLE IS MISBRANDED VIDE SECTION 17(b) AND RULE 96 OF THE DRUGS AND COSMETICS ACT 1940 AND RULES 1945.Dissolution | State Lab MaharashtraState lab | Jun 2024 |
| PANCURE TABLETS (PANTOPRAZOLE TABLETS IP 40 MG) | SLP-18123Mfg 2018-06 · Exp 2020-05 | Test for DissolutionDissolution | CDTL ChennaiCDSCO lab | Apr 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.